Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell

Nora Liebers1,2,3,4, Ariane Boumendil5, Hervé Finel5

  • 1Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.

Blood Cancer Discovery
|February 6, 2025
PubMed
Abstract